Local cefuroxime tissue concentrations in the hand after single and repeated administration to 16 patients undergoing trapeziectomy: a randomized controlled trial

Authors

  • Andrea René Jørgensen Aarhus Denmark Microdialysis Research Group (ADMIRE), Orthopaedic Research Unit, Aarhus University Hospital, Aarhus; Department of Clinical Medicine, Aarhus University, Aarhus
  • Pelle Hanberg Aarhus Denmark Microdialysis Research Group (ADMIRE), Orthopaedic Research Unit, Aarhus University Hospital, Aarhus
  • Mats Bue Aarhus Denmark Microdialysis Research Group (ADMIRE), Orthopaedic Research Unit, Aarhus University Hospital, Aarhus; Department of Clinical Medicine, Aarhus University, Aarhus; Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus https://orcid.org/0000-0001-7215-8323
  • Charlotte Hartig-Andreasen Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus
  • Nis Pedersen Jørgensen Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
  • Maiken Stilling Aarhus Denmark Microdialysis Research Group (ADMIRE), Orthopaedic Research Unit, Aarhus University Hospital, Aarhus; Department of Clinical Medicine, Aarhus University, Aarhus; Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus https://orcid.org/0000-0002-4530-2075

DOI:

https://doi.org/10.2340/17453674.2024.41343

Keywords:

Cefuroxime, Infection, Microdialysis, Prophylaxis, Tissue pharmacokinetics

Abstract

Background and purpose: The duration of antibiotic coverage in hand tissues during surgery is unknown. We investigated the time the free concentration of cefuroxime was above the minimal inhibitory concentration (fT>MIC) of 4 μg/mL in hand tissues after single and repeated administration.
Methods: In a prospective, unblinded randomized study 16 patients (13 female, age range 51–80 years) underwent trapeziectomy. Microdialysis catheters were placed in the metacarpal bone (primary effect parameter), synovial sheath, and subcutaneous tissue. Patients were randomized to postoperative administration of either intravenous single administration of cefuroxime (1,500 mg) (Group 1, n = 8) or repeated dosing (2 x 1,500 mg) with a 4 h interval (Group 2, n = 8). Samples were taken over 8 h.
Results: The fT>MIC of 4 μg/mL was found to be significantly longer in the metacarpal bone in Group 2 compared with Group 1 with a mean difference of 199 min (95% confidence interval 158–239). The same trend was evident in the remaining compartments. A concentration of 4 μg/mL was reached in all compartments in both groups within a mean time of 6 min (range 0–27 min). In Group 1, the mean concentrations decreased below 4 μg/mL between 3 h 59 min and 5 h 38 min.
Conclusion: The fT>MIC was longer after repeated administration compared with single administration in all compartments. A single administration of cefuroxime 1,500 mg provided antimicrobial hand tissue coverage for a minimum of 3 h 59 min. Cefuroxime administration in hand surgeries should be done minimum 27 min prior to incision to achieve sufficient coverage in all individuals. Cefuroxime readministration should be considered in hand surgeries lasting longer than 4 h from time of administration.

Downloads

Download data is not yet available.

References

Bykowski M R, Sivak W N, Cray J, Buterbaugh G, Imbriglia J E, Lee W P. Assessing the impact of antibiotic prophylaxis in outpatient elective hand surgery: a single-center, retrospective review of 8,850 cases. J Hand Surg Am 2011; 36: 1741-7. doi: 10.1016/j.jhsa.2011.08.005. DOI: https://doi.org/10.1016/j.jhsa.2011.08.005

Eberlin K R, Ring D. Infection after hand surgery. Hand Clin 2015; 31: 355-60. doi: 10.1016/j.hcl.2014.12.007. DOI: https://doi.org/10.1016/j.hcl.2014.12.007

Elek S D. Experimental staphylococcal infections in the skin of man. Ann N Y Acad Sci 1956; 65: 85-90. doi: 10.1111/j.1749-6632.1956.tb36626.x. DOI: https://doi.org/10.1111/j.1749-6632.1956.tb36626.x

Berríos-Torres S I, Umscheid C A, Bratzler D W, Leas B, Stone E C, Kelz R R, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg 2017; 152: 784-791. doi: 10.1001/jamasurg.2017.0904. DOI: https://doi.org/10.1001/jamasurg.2017.0904

Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg 2008; 16: 283-93. doi: 10.5435/00124635-200805000-00007. DOI: https://doi.org/10.5435/00124635-200805000-00007

Bratzler D W, Houck P M. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38: 1706-15. doi: 10.1086/421095. DOI: https://doi.org/10.1086/421095

Hanberg P, Bue M, Kabel J, Jørgensen A R, Jessen C, Søballe K, et al. Effects of tourniquet inflation on peri- and postoperative cefuroxime concentrations in bone and tissue. Acta Orthop 2021; 92: 746-52. doi: 10.1080/17453674.2021.1942620. DOI: https://doi.org/10.1080/17453674.2021.1942620

Hvistendahl M A, Bue M, Hanberg P, Kaspersen A E, Schmedes A V, Stilling M, et al. Cefuroxime concentrations in the anterior and posterior column of the lumbar spine: an experimental porcine study. Spine J 2022; 22: 1434-41. doi: 10.1016/j.spinee.2022.05.010. DOI: https://doi.org/10.1016/j.spinee.2022.05.010

Tøttrup M, Søballe K, Bibby B M, Hardlei T F, Hansen P, Fuursted K, et al. Bone, subcutaneous tissue and plasma pharmacokinetics of cefuroxime in total knee replacement patients: a randomized controlled trial comparing continuous and short-term infusion. APMIS 2019; 127: 779-88. doi: 10.1111/apm.12996. DOI: https://doi.org/10.1111/apm.12996

EUCAST. MIC EUCAST. 2022. Available from: https://mic.eucast.org/search/?search%5Bmethod%5D=mic&search%5Bantibiotic%5D=-1&search%5Bspecies%5D=449&search%5Bdisk_content%5D=-1&search%5Blimit%5D=50

Saeed K, McLaren A C, Schwarz E M, Antoci V, Arnold W V, Chen A F, et al. 2018 international consensus meeting on musculoskeletal infection: summary from the biofilm workgroup and consensus on biofilm related musculoskeletal infections. J Orthop Res 2019; 37: 1007-17. doi: 10.1002/jor.24229 DOI: https://doi.org/10.1002/jor.24229

Houshian S, Seyedipour S, Wedderkopp N. Epidemiology of bacterial hand infections. Int J Infect Dis 2006; 10: 315-19. doi: 10.1016/j.ijid.2005.06.009. DOI: https://doi.org/10.1016/j.ijid.2005.06.009

Kaukonen J P, Tuomainen P, Makijarvi J, Mokka R, Mannisto P T. Intravenous cefuroxime prophylaxis: tissue levels after one 3-gram dose in 40 cases of hip fracture. Acta Orthop Scand 1995; 66: 14-16. doi: 10.3109/17453679508994631. DOI: https://doi.org/10.3109/17453679508994631

Kho C M, Enche Ab Rahim S K, Ahmad Z A, Abdullah N S. A review on microdialysis calibration methods: the theory and current related efforts. Mol Neurobiol 2017; 54: 3506-27. doi: 10.1007/s12035-016-9929-8. DOI: https://doi.org/10.1007/s12035-016-9929-8

Hanberg P, Bue M, Obrink-Hansen K, Kabel J, Thomassen M, Tottrup M, et al. Simultaneous retrodialysis by drug for cefuroxime using meropenem as an internal standard: a microdialysis validation study. J Pharm Sci 2019; 10.1016/j.xphs.2019.11.014. doi: 10.1016/j.xphs.2019.11.014. DOI: https://doi.org/10.1016/j.xphs.2019.11.014

Hanberg P, Obrink-Hansen K, Thorsted A, Bue M, Tottrup M, Friberg L E, et al. Population pharmacokinetics of meropenem in plasma and subcutis from patients on extracorporeal membrane oxygenation treatment. Antimicrob Agents Chemother 2018; 62. doi: 10.1128/aac.02390-17. DOI: https://doi.org/10.1128/AAC.02390-17

Jørgensen A R, Hanberg P, Bue M, Thomassen M B, Pedersen Jørgensen N, Stilling M. Double-dose cefuroxime concentrations in bone, synovial fluid of the knee joint and subcutaneous adipose tissue: a randomised porcine microdialysis study. Eur J Pharm Sci 2021; 160: 105754. doi: 10.1016/j.ejps.2021.105754. DOI: https://doi.org/10.1016/j.ejps.2021.105754

Craig W A. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26: 1-10; quiz 11-12. doi: 10.1086/516284. DOI: https://doi.org/10.1086/516284

Rizvi M, Bille B, Holtom P, Schnall S B. The role of prophylactic antibiotics in elective hand surgery. J Hand Surg Am 2008; 33: 413-20. doi: 10.1016/j.jhsa.2007.12.017. DOI: https://doi.org/10.1016/j.jhsa.2007.12.017

Tøstesen S K, Hanberg P, Bue M, Thillemann T M, Falstie-Jensen T, Tøttrup M, et al. Weight-based cefuroxime dosing provides comparable orthopedic target tissue concentrations between weight groups: a microdialysis porcine study. APMIS 2022; 130: 111-18. doi: 10.1111/apm.13198. DOI: https://doi.org/10.1111/apm.13198

Giladi A M, Malay S, Chung K C. A systematic review of the management of acute pyogenic flexor tenosynovitis. J Hand Surg Eur 2015; 40: 720-8. doi: 10.1177/1753193415570248. DOI: https://doi.org/10.1177/1753193415570248

Jensen L K, Koch J, Henriksen N L, Bue M, Tøttrup M, Hanberg P, et al. Suppurative inflammation and local tissue destruction reduce the penetration of cefuroxime to infected bone implant cavities. J Comp Pathol 2017; 157: 308-16. doi: 10.1016/j.jcpa.2017.10.001. DOI: https://doi.org/10.1016/j.jcpa.2017.10.001

Tøttrup M, Bue M, Koch J, Jensen L K, Hanberg P, Aalbæk B, et al. Effects of implant-associated osteomyelitis on cefuroxime bone pharmacokinetics: assessment in a porcine model. J Bone Joint Surg Am 2016; 98: 363-9. doi: 10.2106/jbjs.O.00550. DOI: https://doi.org/10.2106/JBJS.O.00550

Published

2024-09-06

How to Cite

Jørgensen, A. R., Hanberg, P., Bue, M., Hartig-Andreasen, C., Jørgensen, N. P., & Stilling, M. (2024). Local cefuroxime tissue concentrations in the hand after single and repeated administration to 16 patients undergoing trapeziectomy: a randomized controlled trial. Acta Orthopaedica, 95, 498–504. https://doi.org/10.2340/17453674.2024.41343

PlumX (by Elsevier) is an altmetrics platform that tracks and visualizes the online attention, usage, captures, citations, and social media engagement.